JPWO2024014524A5 - - Google Patents

Info

Publication number
JPWO2024014524A5
JPWO2024014524A5 JP2024533757A JP2024533757A JPWO2024014524A5 JP WO2024014524 A5 JPWO2024014524 A5 JP WO2024014524A5 JP 2024533757 A JP2024533757 A JP 2024533757A JP 2024533757 A JP2024533757 A JP 2024533757A JP WO2024014524 A5 JPWO2024014524 A5 JP WO2024014524A5
Authority
JP
Japan
Prior art keywords
patients
administration
statin
ldl cholesterol
methoxyphenoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533757A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024014524A1 (cg-RX-API-DMAC7.html
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/025980 external-priority patent/WO2024014524A1/ja
Publication of JPWO2024014524A1 publication Critical patent/JPWO2024014524A1/ja
Publication of JPWO2024014524A5 publication Critical patent/JPWO2024014524A5/ja
Pending legal-status Critical Current

Links

JP2024533757A 2022-07-15 2023-07-14 Pending JPWO2024014524A1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022113930 2022-07-15
PCT/JP2023/025980 WO2024014524A1 (ja) 2022-07-15 2023-07-14 血中ldlコレステロール低下剤

Publications (2)

Publication Number Publication Date
JPWO2024014524A1 JPWO2024014524A1 (cg-RX-API-DMAC7.html) 2024-01-18
JPWO2024014524A5 true JPWO2024014524A5 (cg-RX-API-DMAC7.html) 2026-06-23

Family

ID=89536850

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533757A Pending JPWO2024014524A1 (cg-RX-API-DMAC7.html) 2022-07-15 2023-07-14

Country Status (8)

Country Link
US (1) US20260014122A1 (cg-RX-API-DMAC7.html)
EP (1) EP4556006A4 (cg-RX-API-DMAC7.html)
JP (1) JPWO2024014524A1 (cg-RX-API-DMAC7.html)
KR (1) KR20250034041A (cg-RX-API-DMAC7.html)
CN (1) CN119546300A (cg-RX-API-DMAC7.html)
JO (1) JOP20250007A1 (cg-RX-API-DMAC7.html)
TW (1) TW202408500A (cg-RX-API-DMAC7.html)
WO (1) WO2024014524A1 (cg-RX-API-DMAC7.html)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20110009T1 (hr) 2003-09-03 2011-03-31 Kowa Co. Spoj kojim se aktivira ppar i farmaceutski pripravak koji ga sadrži
TWI696462B (zh) * 2013-07-10 2020-06-21 日商興和股份有限公司 非酒精性脂肪性肝疾病治療劑
PT3275438T (pt) * 2016-07-29 2021-01-25 Kowa Co Métodos de prevenção de eventos cardiovasculares em populações dislipidémicas de risco residual
US11446282B2 (en) * 2017-12-21 2022-09-20 Kowa Company, Ltd. Methods of treating mixed dyslipidemia and hypertriglycertdemia
CA3085951C (en) * 2017-12-21 2022-10-11 Kowa Company, Ltd. Methods of treatment of hypertriglyceridemia
EP4346809B1 (en) * 2021-05-27 2026-07-15 Kowa Company, Ltd. Pemafibrate for use in treating liver disease